4Filed Aug 2, 8:00 PM ET
Kestra Medical (KMTS) CCO Alfred J. Ford Jr Sells Shares
$KMTS · KESTRA MEDICAL TECHNOLOGIES, LTD.Research Summary
AI-generated summary of this SEC filing
Kestra Medical (KMTS) CCO Alfred J. Ford Jr Sells Shares
What Happened
- Alfred J. Ford Jr., Chief Commercial Officer of Kestra Medical Technologies (KMTS), disposed of 27,632 shares in three open-market sales to satisfy tax withholding obligations tied to RSU vesting. The three transactions totaled approximately $642,523.
- Trade details: 5,936 shares on 2026-07-30 at a weighted avg $22.76 for $135,121; 8,681 shares on 2026-07-31 at $22.61 for $196,284; and 13,015 shares on 2026-08-03 at $23.90 for $311,118. These were sales (routine liquidity / tax withholding), not purchases.
Key Details
- Transaction dates & reported weighted-average prices:
- 2026-07-30: 5,936 shares @ $22.76 — $135,121
- 2026-07-31: 8,681 shares @ $22.61 — $196,284
- 2026-08-03: 13,015 shares @ $23.90 — $311,118
- Total shares sold: 27,632; total proceeds: ≈ $642,523.
- Shares owned after the transactions: not specified in the filing.
- Notable footnotes:
- F1: These sales were nondiscretionary "sell-to-cover" transactions to satisfy tax withholding related to the vesting and settlement of restricted stock units.
- F2–F4: Reported prices are weighted averages; the filing lists sale price ranges across the trades (approximately $22.17 to $24.28). The reporting person can provide a breakdown by price on request.
- Filing timeliness: Form 4 was filed on 2026-08-03 covering transactions on 2026-07-30, 07-31 and 08-03; the filing appears to be timely.
Context
- These were sell-to-cover tax withholding sales tied to RSU settlement, which are routine and common when equity awards vest; such transactions are not the same signal as voluntary insider purchases.
- For retail investors, purchases by insiders can be more informative of confidence; routine tax-related disposals generally reflect administrative needs rather than a directional view on the stock.